• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Nio's Charts Suggest Further Declines Ahead

The level for the bulls to defend is the $35 area.
By BRUCE KAMICH
Apr 06, 2021 | 11:38 AM EDT
Stocks quotes in this article: NIO

During Monday's Lightning Round segment of Mad Money, one caller asked Jim Cramer about NIO Ltd  (NIO) : "This one needs to come down. These stocks are too expensive," said Cramer referring to the electric vehicle (EV) space.

We looked at NIO back on February 18 and recommended, "Continue to be prepared for lower prices either by selling here or on a close sell stop -- the Point and Figure chart suggests $49, but a decline to the bottom end of support around $40 could also happen."  

Let's pay another visit to the charts. 
 
In this daily bar chart of NIO, below, we can see that our February 17 forecast worked out nicely. Now that our $40 price target was reached and overshot, another review is needed. We can see that prices dipped close to the rising 200-day moving average line in early March and again in late March. The slope of the 200-day line is positive but the 50-day average line has a negative slope.
 
The On-Balance-Volume (OBV) line shows a decline from the middle of January to late March telling us that sellers of NIO have been more aggressive. The Moving Average Convergence Divergence (MACD) oscillator gave a sell signal in late February and two cover shorts buy signals in March.  
 
 
In this weekly Japanese candlestick chart of NIO, below, we see a mixed picture. We can see that NIO has tested its rising 40-week moving average line. Prices have bounced off of the rising line but not with a lot of "vigor" and the trading volume is not showing an increase by traders convinced the pullback is over.
 
The weekly OBV line still shows weakness from November, and the MACD oscillator is still pointed down from a take profit sell signal. 
 
 
 
In this daily Point and Figure chart of NIO, below, we can see that the software is projecting the $25 area as a potential downside price target.  
 
 
 
Bottom line strategy: We have been successful so far avoiding the long side of NIO. Prices have held the $35 area twice in March so that is the level for the bulls to defend. A break of this support zone could open the way to declines in the $25 area, according to the Point and Figure chart. 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Markets | Stocks | Technical Analysis | Trading | Automotive | China | Mad Money | Electric Vehicles

More from Investing

Market's 'Superficial' Highs Are Only Skin Dip

James "Rev Shark" DePorre
Apr 9, 2021 4:36 PM EDT

You can't call this market overbought when so much of it isn't participating.

Pinterest: Double Top or Breakout Pending?

Bruce Kamich
Apr 9, 2021 3:00 PM EDT

What would I do in this case? Here's the logical choice.

I'm Continuing to Build a Position in Skillz

Timothy Collins
Apr 9, 2021 2:24 PM EDT

SKLZ shows explosion moves to the upside when it emerges from the oversold area.

Royalty Pharma Shows Promise

Bruce Kamich
Apr 9, 2021 1:10 PM EDT

Here's how traders should play RPRX right now.

Making the Best of the Peculiar Market Action

James "Rev Shark" DePorre
Apr 9, 2021 12:17 PM EDT

Trading in biotech stocks and a particular SPAC play are on my mind.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 04:44 PM EDT PAUL PRICE

    Pretty Incredible + Hard to Believe

  • 11:18 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The 5 Pillars of Exceptional Trading
  • 08:05 AM EDT BOB LANG

    Bitcoin vs. Gold: Which Should You Invest In Now?

    Read my article TheStreet here!
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login